Association of intraoperative opioids with improved recurrence-free survival in triple-negative breast cancer.

被引:0
|
作者
Montagna, Giacomo
Hannum, Margaret L.
Tan, Kay See
Plitas, George
McCormick, Patrick J.
Fischer, Gregory W.
Morrow, Monica
Mincer, Joshua S.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Biostat Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
542
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer
    Montagna, Giacomo
    Gupta, Hersh V.
    Hannum, Margaret
    Tan, Kay See
    Lee, Jasme
    Scarpa, Joseph R.
    Plitas, George
    Irie, Takeshi
    McCormick, Patrick J.
    Fischer, Gregory W.
    Morrow, Monica
    Mincer, Joshua S.
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (02) : 367 - 376
  • [2] Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
    Bae, Min Sun
    Shin, Sung Ui
    Ryu, Han Suk
    Han, Wonshik
    Im, Seock-Ah
    Park, In-Ae
    Noh, Dong-Young
    Moon, Woo Kyung
    RADIOLOGY, 2016, 281 (02) : 392 - 400
  • [3] Recurrence and survival after pulmonary metastasis in triple-negative breast cancer.
    Gadiyaram, V. K.
    Kurian, S.
    Abraham, J.
    Ducatman, B.
    Hazard, H.
    Hobbs, G.
    Vona-Davis, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients
    Pedersen, Martin H.
    Hood, Brian L.
    Ehmsen, Sidse
    Beck, Hans C.
    Conrads, Thomas P.
    Bak, Martin
    Ditzel, Henrik J.
    Leth-Larsen, Rikke
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 631 - 640
  • [5] DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
    Mary Jo Fackler
    Soonweng Cho
    Leslie Cope
    Edward Gabrielson
    Kala Visvanathan
    Kathleen Wilsbach
    Danielle Meir-Levi
    Charles F. Lynch
    Jeffrey Marks
    Joseph Geradts
    Meredith M. Regan
    Giuseppe Viale
    Antonio C. Wolff
    Saraswati Sukumar
    Christopher B. Umbricht
    npj Breast Cancer, 6
  • [6] DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
    Fackler, Mary Jo
    Cho, Soonweng
    Cope, Leslie
    Gabrielson, Edward
    Visvanathan, Kala
    Wilsbach, Kathleen
    Meir-Levi, Danielle
    Lynch, Charles F.
    Marks, Jeffrey
    Geradts, Joseph
    Regan, Meredith M.
    Viale, Giuseppe
    Wolff, Antonio C.
    Sukumar, Saraswati
    Umbricht, Christopher B.
    NPJ BREAST CANCER, 2020, 6 (01)
  • [7] Triple-Negative Breast Cancer: Pattern of Recurrence and Survival Outcomes
    Chintalapani, Shyny Reddy
    Bala, Stalin
    Konatam, Meher Lakshmi
    Gundeti, Sadashivudu
    Kuruva, Siva Prasad
    Hui, Monalisa
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (01) : 67 - 72
  • [8] Post-recurrence survival in triple negative breast cancer.
    Morante, Zaida
    Ku, Gabriel Antonio De la Cruz
    Enriquez, Daniel
    Saavedra, Antonella
    Lujan, Maria
    Luque, Renato
    Eyzaguirre, Eduardo
    Guardamino, David
    Valcárcel, Bryan
    Araujo, Jhajaira M.
    Pinto, Joseph
    Alejandro Fuentes, Hugo
    Neciosup, Silvia P.
    Leonidas Gomez, Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy
    Zhao, Jingwei
    Zhang, Qi
    Liu, Muqing
    Zhao, Xinming
    MEDICINE, 2023, 102 (42) : E35646